Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | CGS Administrators | Computed Tomography Cerebral Perfusion Analysis (CTP) | Codes changed |
| May 17, 2026 | CGS Administrators | Implantable Continuous Glucose Monitors (I-CGM) | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Pharmacogenomics Testing | Codes changed |
| May 17, 2026 | CGS Administrators | Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH) | Codes changed |
| May 17, 2026 | CGS Administrators | Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Repeat Germline Testing | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | Codes changed |
| May 17, 2026 | CGS Administrators | Immune Thrombocytopenia (ITP) Therapy | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Blood Product Molecular Antigen Typing | Codes changed |
| May 17, 2026 | CGS Administrators | Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Pigmented Lesion Assay | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Next-Generation Sequencing for Solid Tumors | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Melanoma Risk Stratification Molecular Testing | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Codes changed |
| May 17, 2026 | CGS Administrators | Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic conditions | Codes changed |
| May 17, 2026 | CGS Administrators | MDS FISH | Codes changed |
| May 17, 2026 | CGS Administrators | Cystatin C Measurement | Codes changed |
| May 17, 2026 | CGS Administrators | Micro-Invasive Glaucoma Surgery (MIGS) | Codes changed |
| May 17, 2026 | CGS Administrators | Frequency of Hemodialysis | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: EndoPredict Breast Cancer Gene Expression Test | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Prometheus IBD sgi Diagnostic® Policy | Codes changed |
| May 17, 2026 | CGS Administrators | Chiropractic Services | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: DecisionDx-UM (Uveal Melanoma) | Codes changed |
| May 17, 2026 | CGS Administrators | Coenzyme Q10 (CoQ10) | Codes changed |
| May 17, 2026 | CGS Administrators | Bladder/Urothelial Tumor Markers | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | Codes changed |
| May 17, 2026 | CGS Administrators | GlycoMark® Testing for Glycemic Control | Codes changed |
| May 17, 2026 | CGS Administrators | Polysomnography and Other Sleep Studies | Codes changed |
| May 17, 2026 | CGS Administrators | Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities | Codes changed |
| May 17, 2026 | CGS Administrators | ProMark® Risk Score | Codes changed |
| May 17, 2026 | CGS Administrators | Proton Beam Therapy | Codes changed |
| May 17, 2026 | CGS Administrators | <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b> | Codes changed |
| May 17, 2026 | CGS Administrators | Transcranial Magnetic Stimulation (TMS) | Codes changed |
| May 17, 2026 | CGS Administrators | Bone Mass Measurement | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Breast Cancer Assay: Prosigna® | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Biomarkers in Cardiovascular Risk Assessment | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: MGMT Promoter Methylation Analysis | Codes changed |
| May 17, 2026 | CGS Administrators | Urine Drug Testing | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Molecular Diagnostic Tests (MDT) | Codes changed |
| May 17, 2026 | CGS Administrators | Special Histochemical Stains and Immunohistochemical Stains | Codes changed |
| May 17, 2026 | CGS Administrators | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Codes changed |
| May 17, 2026 | CGS Administrators | Somatosensory Testing | Codes changed |